Otsuka Pharmaceutical Co., Ltd v. Aurobindo Pharma Ltd

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Docket number

1:19-cv-01965

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

10/16/2019

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Otsuka Pharmaceutical Co., Ltd · 137 cases
• defendant · Aurobindo Pharma Ltd · 167 cases

Part of a Larger Litigation Pattern

This is one of 168 Patent - ANDA cases in our index naming AUROBINDO PHARMA LTD — a possible mass-tort or coordinated-litigation cluster.

• Amicus Therapeutics US, LLC v. Aurobindo Pharma Ltd
  District Court, D. DelawareFiled 12/06/2024
• Cassiopea S.P.A v. Aurobindo Pharma Ltd
  District Court, D. New JerseyFiled 11/25/2024
• Supernus Pharmaceuticals, Inc v. Aurobindo Pharma Ltd
  District Court, D. New JerseyFiled 09/23/2024
• Amicus Therapeutics US, LLC v. Aurobindo Pharma Ltd
  District Court, D. DelawareFiled 06/13/2024
• Bayer HealthCare LLC v. Aurobindo Pharma Ltd
  District Court, D. DelawareFiled 03/28/2024
• Azurity Pharmaceuticals, Inc v. Aurobindo Pharma Ltd
  District Court, D. New JerseyFiled 12/21/2023

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Otsuka Pharmaceutical Co., Ltd v. Aurobindo Pharma Ltd?

Otsuka Pharmaceutical Co., Ltd v. Aurobindo Pharma Ltd is a federal patent - anda lawsuit filed on 10/16/2019 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:19-cv-01965.

When was the case filed?

Otsuka Pharmaceutical Co., Ltd v. Aurobindo Pharma Ltd was filed on 10/16/2019. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.